1. Home
  2. TOUR vs ACRS Comparison

TOUR vs ACRS Comparison

Compare TOUR & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOUR
  • ACRS
  • Stock Information
  • Founded
  • TOUR 2006
  • ACRS 2012
  • Country
  • TOUR China
  • ACRS United States
  • Employees
  • TOUR N/A
  • ACRS N/A
  • Industry
  • TOUR Transportation Services
  • ACRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOUR Consumer Discretionary
  • ACRS Health Care
  • Exchange
  • TOUR Nasdaq
  • ACRS Nasdaq
  • Market Cap
  • TOUR 98.6M
  • ACRS 165.7M
  • IPO Year
  • TOUR 2014
  • ACRS 2015
  • Fundamental
  • Price
  • TOUR $0.94
  • ACRS $1.81
  • Analyst Decision
  • TOUR
  • ACRS Strong Buy
  • Analyst Count
  • TOUR 0
  • ACRS 9
  • Target Price
  • TOUR N/A
  • ACRS $9.25
  • AVG Volume (30 Days)
  • TOUR 311.0K
  • ACRS 800.9K
  • Earning Date
  • TOUR 08-15-2025
  • ACRS 11-05-2025
  • Dividend Yield
  • TOUR 3.82%
  • ACRS N/A
  • EPS Growth
  • TOUR N/A
  • ACRS N/A
  • EPS
  • TOUR 0.03
  • ACRS N/A
  • Revenue
  • TOUR $75,532,120.00
  • ACRS $16,789,000.00
  • Revenue This Year
  • TOUR $16.99
  • ACRS N/A
  • Revenue Next Year
  • TOUR $13.23
  • ACRS N/A
  • P/E Ratio
  • TOUR $28.42
  • ACRS N/A
  • Revenue Growth
  • TOUR 7.57
  • ACRS N/A
  • 52 Week Low
  • TOUR $0.75
  • ACRS $1.05
  • 52 Week High
  • TOUR $1.76
  • ACRS $5.17
  • Technical
  • Relative Strength Index (RSI)
  • TOUR 62.47
  • ACRS 44.83
  • Support Level
  • TOUR $0.88
  • ACRS $2.01
  • Resistance Level
  • TOUR $0.96
  • ACRS $2.16
  • Average True Range (ATR)
  • TOUR 0.04
  • ACRS 0.11
  • MACD
  • TOUR 0.01
  • ACRS -0.03
  • Stochastic Oscillator
  • TOUR 87.70
  • ACRS 1.43

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: